eCORE
- Cancer
Team
Group Leader
Antonio Gil Moreno, Eva Colàs
Principal Investigator (PI)
Antonio Gil Moreno, Eva Colás Ortega, Silvia Cabrera Díaz, Melissa Bradbury
Researchers
Cristian Moiola, Carlos López, Javier de la Torre, Martín Espinosa, Assumpció Pérez Benavente, Cristina Centeno, Martina Angeles Fité, Vicente Bebia, Anna Luzarraga, Laura Mañalich, Elena Suárez, Montse Cubo, Sonia Monreal, Diana Guerrero, Ursula Acosta, Josep Castellvi, Angel García, Carme Dinarés, Anna Ruano, Sabina Salicrú, Christian Sisó
PhD Students
Carina Masferrer, Beatriz Villafranca, Melek Denizli, Irene de la Calle, Raquel Delgado
Lab Technicians
Marta Rebull, Francesc Serra
Nursing and Technical Staff
Elisabeth Olivan
Selected Publications
Aznar AL, Canton R, Loren G, Carvajal J, de la Calle I, Masferrer-Ferragutcasas C, Serra F, Bebia V, Bonaldo G, Angeles MA, Cabrera S, Palomar N, Vilarmau C, Martí M, Rigau M, Colas E, Gil-Moreno A.
Current challenges and emerging tools in endometrial cancer diagnosis.
Int J Gynecol Cancer. 2024 Dec 18:100056
DOI: 10.1016/j.ijgc.2024.100056
IF: 4.1
Casas-Arozamena C, Vilar A, Cueva J, Arias E, Sampayo V, Diaz E, Oltra SS, Moiola CP, Cabrera S, Cortegoso A, Curiel T, Abalo A, Pamies Serrano M, Domingo S, Padilla-Iserte P, Arnaez de la Cruz M, Hernández A, García-Pineda V, Ruiz-Bañobre J, López R, Matias-Guiu X, Colás E, Gil-Moreno A, Abal M, Moreno-Bueno G, Muinelo-Romay L.
Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application.
J Exp Clin Cancer Res. 2024 Sep 20;43(1):264.
DOI: 10.1186/s13046-024-03158-w
IF: 11.4
Cabrera S, Bebia V, López-Gil C, Luzarraga-Aznar A, Denizli M, Salazar-Huayna L, Abdessayed N, Castellví J, Colas E, Gil-Moreno A.
Molecular classification improves preoperative risk assessment of endometrial cancer.
Gynecol Oncol. 2024 Oct;189:56-63.
DOI: 10.1016/j.ygyno.2024.07.003
IF: 4.5
Luzarraga Aznar, A., Bebia, V., López-Gil, C., Villafranca-Magdalena, B., Salazar-Huayna, L., Castellvi, J., Colàs, E., Gil-Moreno, A., & Cabrera, S.
Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer.
International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 2024 May 6; 34(5), 659–666.
DOI: 10.1136/ijgc-2023-005165
IF: 4.5
Bonaldo G, De Vitis LA, Pérez-Benavente A, Gil-Moreno A, Multinu F.
Pocket reference based on the International Federation of Gynecology and Obstetrics (FIGO) staging of endometrial cancer 2023.
Int J Gynecol Cancer. 2024 Dec 2;34(12):1993-1995
DOI: 10.1136/ijgc-2024-005826
IF: 4.1
Selected Projects
Desarrollo de un test no invasivo para el diagnóstico de cáncer de endometrio basado en la detección de marcadores proteicos en biopsia líquida cervical. (PI23/01470)
Principal Investigator: Eva Colás
Agency: Instituto de Salud Carlos III
Funding: 177,500 €
Period: 2024-2026
CytoMARK: Development of a personalised non-invasive diagnosis of endometrial cancer using proteomic markers in cervical fluids and clinical data. (ERAPERMED2021-146_CytoMARK)
Principal Investigator: Eva Colás
Agency: Instituto de Salud Carlos III, Asociación Española Contra el Cáncer
Funding: 824,933 €
Period: 2022-2025
ScreenEC: Development of a non-invasive IVD for endometrial cancer screening on high-risk populations. (CPP2022-009817)
Principal Investigator: Eva Colás
Agency: Ministerio de Ciencia e Innovación
Funding: 1,506,847 € (VHIR 210,920 €)
Period: 2023-2026
Desarrollo de CEMARK-Px, un método in vitro para el diagnóstico objetivo y preciso del tipo y grado histológico del cáncer de endometrio en fluido uterino. (DTS23/00091)
Principal Investigator: Eva Colás
Agency: Instituto de Salud Carlos III
Funding: 278,300 €
Period: 2023-2025
ScreenEC, validació d’una eina de triatge no invasiu en càncer d’endometri. (SLT036/24/000059)
Principal Investigator: Eva Colás
Agency: Generalitat de Catalunya
Funding: 99,946 €
Period: 2024-2025
Patents
Biomarkers for endometrial cancer Spain
Priority Number: EP21382680.3
Priority Date: 23/07/2021
Applicants: 80% VHIR / 20% LIH
Markers for endometrial cancer
Priority Number: PCT/EP2018/069841
Priority Date: 21/07/2017
Applicants: 100% VHIR
Markers of endometrial cancer
Priority Number: PCT/EP2017/057635
Priority Date: 04/05/2016
Applicants: 100% VHIR
Selected Dissemination Activities
ENDO-HIT project
Place: High schools in Barcelona
Date: 01/01/1970
Brief: Programme as part of the Caixa d'eines/Pla de Barris citizen science co-creation programme. As part of the ENDO-HIT project, researchers from the team went to schools to raise awareness of menstrual health and inform about endometriosis and associated pain. In addition, information was collected from students on demographics, knowledge of endometriosis, and the impact and importance of the talk. Specifically, these two schools conducted co-creation activities related to the talk in which they actively participated, and made an analysis of the data from the questionnaires.
MORE INFO
EscoLAB
Place: VHIR
Date: 04/10/2024
Brief: Programme organised by Barcelona City Council in which different schools visited the Biomedical Research Group to get in touch with our team and learn about the lines of research we carry out.
MORE INFO
CONÓCELAS
Place: Barcelona schools
Date: 01/01/1970
Brief: Programme promoted by ASEICA, one of the largest cancer research associations in our country. In this programme a group of women scientists connect with institutes at national level to explain and promote STEM careers in institutes.
MORE INFO
International Day of Women and Girls in Science
Place: Barcelona schools
Date: 26/07/2025
Brief: Researchers from the group went to schools to explain the importance of the day, raise awareness of menstrual health and inform about endometriosis and associated pain. Information was also collected from pupils on demographics, knowledge of endometriosis, and the impact and importance of the talk.
Dissemination of the results of our research in the media
Place: VHIR
Date: 26/07/2025
Brief: In recent years, there has been active dissemination both in television programmes (the group's research was one of the topics covered in TV3's Càpsules) and in print and digital newspapers (La Vanguardia, La Razón, etc); radio (Cadena Ser, etc); websites (lavozdigital.es); and social networks (Twitter, LinkedIn).
